Scripps Research
Biotech Innovation Summit
October 2, 2025
La Jolla, California
Catalyzing Connections, Igniting Innovation.
Join us on Thursday, October 2, 2025, for a dynamic program aimed at engaging thought leaders from all ends of the biotech spectrum and promoting impactful collaborations by connecting pioneering Scripps Research innovators with visionary investors.
Created in partnership with the Strategic Investment Committee, this year’s event will feature a series of keynotes, fireside chats and networking opportunities. These networking conversations—including one-on-one partnering meetings between Scripps faculty and business development leaders from biotech, pharma, and venture capital—offer organizations a unique opportunity to engage directly with Scripps Research investigators pioneering exciting early-stage innovations.
Save the date! Be the first to know when event registration opens:
This event is by invitation only. All registration submissions will be reviewed internally. If approved, you will receive an email confirmation with details about the event.
About Scripps Research
Founded 100 years ago, Scripps Research is globally renowned in the life sciences and chemistry for scientific excellence and for training the scientific leaders of tomorrow. Ranked by Nature Index among the world’s top five most innovative institutes, we empower our scientists to pursue high-risk, high-reward ideas that transform our understanding of the world and lead to new technologies that shape our future.
Our faculty pursue highly interdisciplinary research, bridging the fields of chemistry, neuroscience, structural and computational biology, cellular and molecular biology, and immunology. Among their many contributions are major advances in understanding the adaptive and innate immune systems, sensory neurobiology and cellular signaling, and they have pioneered technologies in chemical synthesis, synthetic biology and biotechnology. Our scientists have played a pivotal role in the development of 17 FDA-approved drugs and vaccines.
